LoVo nuclear extract

for LoVo nuclear extractContents

200 µg of LoVo nuclear extract at 7.19 µg/µl.

for LoVo nuclear extractBackground

LoVo nuclear extract was prepared from cell cultures of the human colon adenocarcinoma LoVo nuclear cell line. The LoVo cell line was derived from a metastatic nodule in the left supraclavicular region of a 56 year old Caucasian male patient with adenocarcinoma of the colon. These cells display an epithelial morphology and retain the characteristics of their tissue of origin, including the expression of carcinoembryonic antigen (CEA), the formation of acinar structures, and the presence of microvilli and desmosomes. Because these cells retain the properties of malignant intestinal cells, they are most commonly used in research as in vitro models for colorectal cancer to study tumorigenicity, cytotoxicity, and pharmacodynamics.

for LoVo nuclear extractApplication Notes

LoVo nuclear extract nuclear extract is specifically recommended for studies related to colorectal cancer.

for LoVo nuclear extractExtract Origin

Human epithelial colon metastatic cells

for LoVo nuclear extractExtract Composition

LoVo nuclear extract is supplied in Dilution Buffer (20 mM Hepes (pH 7.9), 100 mM KCl, 1 mM MgCl₂, 20% glycerol, 0.5 mM PMSF and 0.5 mM DTT).

for LoVo nuclear extractQuality Control

Extracts have been quality control tested by Western blot and the Electrophoretic Mobility Shift Assay (EMSA).

for LoVo nuclear extractStorage

To ensure stability, extracts should be stored at -80°C.

We recommend aliquoting the extracts into single-use fractions and then storing them at -80°C. This eliminates repeated freeze/thaw cycles.

for LoVo nuclear extractGuarantee

This product is guaranteed for 6 months from date of receipt.

This product is for research use only and is not for use in diagnostic procedures.